Similar articles

• [Use of frozen thrombocytes for the determination of von willebrand factor with the aid of ristocetin].

  Caduff T, Straub PW. Caduff T, et al. Schweiz Med Wochenschr. 1979 Mar 17;109(11):399-402. Schweiz Med Wochenschr. 1979. PMID: 34214 German.
• Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.

  Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma JP, Vicic WJ, Rogers J. Weiss HJ, et al. N Engl J Med. 1982 Feb 11;306(6):326-33. doi: 10.1056/NEJM198202113060603. N Engl J Med. 1982. PMID: 6798442
• Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.

  Dowling SV, Muntz RH, D'Souza S, Ekert H. Dowling SV, et al. Thromb Diath Haemorrh. 1975 Nov 15;34(2):465-74. Thromb Diath Haemorrh. 1975. PMID: 1081746
• [Pathophysiology of platelet anomalies and its analysis. (4). Abnormality of the platelet function in von Willebrand's disease].

  Yoshioka A, Takahashi Y. Yoshioka A, et al. Rinsho Byori. 1983 Nov;31(11):1176-85. Rinsho Byori. 1983. PMID: 6423868 Review. Japanese. No abstract available.
• [Structure and function of clotting factor VIII: the results of fundamental research].

  Beck EA, Furlan M. Beck EA, et al. Ther Umsch. 1979 Apr;36(4):294-300. Ther Umsch. 1979. PMID: 377554 Review. German. No abstract available.